A discussion on the costs
versus the benefits of the war on drugs has been going on for decades
now. There are approximately 30,000 Australian in jail for drug
offences or for crimes committed related to drugs. A fourth of
violent crimes are connected to illicit drugs.1 The
question of whether criminalising drug use makes sense is a question
that concerns society, but not the workplace in terms of a zero
tolerance policy. Drug and alcohol use in the workplace threatens the
safety of workers, so it really does not matter if there is a war on
drugs or not. There is absolutely no room in the workplace for them.
However, what does matter to employers is that substance abuse is a
problem that is getting worse, and not better. That is the main
message of the World Drug Report 2012, and everyone working to
control drug and alcohol use can learn from it.
The World Drug Report
2012 prepared by the United Nations Office on Drugs and Crime is
filled with disturbing information. There are approximately 230
million people around the world using illicit drugs at least once a
year. It also reports that .2 million people die from using hard
drugs like heroin and cocaine. Drug trafficking is globally
connected, with drugs flowing from continent to continent, country to
country, and region to region. Of particular interest to Australian
employers are the contemporary characteristics and patterns of drug
manufacturing and drug use and their implications for the workplace.
Implication: No Place
Left Untouched by Illicit Drugs
For example, more young
males living in urban areas are using psychoactive substances. The
implication for employers: Greater importance of pre-employment drug
testing for everyone, including persons who are Australian-born and
immigrants or guest workers. Another fact of importance in the World
Drug Report 2012 is that opiate production has fallen over the
last century, but in its place has been a significant increase in the
cocaine market. Implication for drug testing: Using a multi-panel
drug test like the Oraline Saliva Drug Screen in the random drug testing program is important. Another finding was that
Australia and the United States have something in common – they
both have over 1 percent of their populations using opioids (heroin,
opium and non-medical use of synthetic opioids).2
The report goes on to
define the fundamental characteristics of the illicit drug problem
and drug use. One out of every twenty people use illegal drugs at
least once a year. Statistically, an employer with a hundred
employees will have five illicit drug users (aged 15 to 64) in the
workplace. Oceania has high usage rates of cannabis, cocaine and
amphetamine-type stimulants (ATS), and ecstasy use is growing. Other
interesting facts include:
- Persons dependent on illicit drugs are not discouraged by price increases, but will increase usage if market prices decline
- Illicit drug markets are not limited by borders and a global drug economy has formed
- Production of cannabis and ATS is decentralised globally
- 90 percent of opiates are coming for South-West Asia which is the main source for Australia; the balance of opiates come from South-East Asia and Latin America
- The main cocaine drug use markets are North and South America, Western Europe and Oceania
- Australia estimates that illicit drug use annually costs 2.1 billion Australian dollars due to lost productivity
Implication: Random
Drug Testing is Needed
This is just a brief
summary of some of the highlights of the World Drug Report 2012.
It is filled with detailed information concerning global patterns of
drug production and use. Employers should read the full report to get
an overall view of what is happening in the illicit drug world.
The
implication of the report for employers is crystal clear: Random drug
and alcohol test
remains critical to maintaining a safe workplace. The integrity of
random drug testing
programs depends on using quality,
stringently tested products like those supplied by CMM Technology
(cmm.com.au).
This article has been taken from : http://cmm.com.au/articles/learning-from-the-world-drug-report-2012/
No comments:
Post a Comment